Reditus Laboratories
Reditus Laboratories was established with the primary objective of delivering exceptional pathology services to both patients and clinicians. The comprehensive diagnostic testing provided by Reditus has a profound impact on every stage of patient care, ranging from accurate diagnoses to the management of chronic diseases and the provision of curative treatments for acute injuries and illnesses. The company's unwavering mission has always been to offer laboratory testing that is not only precise and easily accessible but also ensures rapid results.
In addition to serving referred and walk-in patients, Reditus Labs has emerged as a prominent leader in COVID laboratory testing for universities and local school districts. Their comprehensive approach includes providing personal protective equipment, on-site testing staff, and a user-friendly web-based portal that offers private access to test results.
Recognizing the critical role of Covid booster shots in the nation's economic recovery, Reditus has forged partnerships with corporate and government entities to facilitate on-site employee testing. Acknowledging that each site and population may present unique challenges and requirements, Reditus Labs tailors its services to meet specific needs. The company works closely with HR departments to implement effective communicable disease testing and surveillance programs. Their extensive program, known as "Reditus FluV19," enables the detection of COVID, Influenza A, and Influenza B.
When widespread testing of the general public becomes necessary, Reditus promptly organizes and conducts concierge events at public locations. These events offer convenient testing options, including drive-ups, walk-ins, and appointment-based services, ensuring accessibility for all. With a remarkable capacity to conduct over 40,000 Covid-19 tests per day and boasting a specificity and sensitivity rate surpassing 98.9%, Reditus has played a pivotal role in ensuring community safety and facilitating a return to normalcy.
At the helm of Reditus Laboratories is Dr. Aaron Rossi, MD, the esteemed founder and CEO. Dr. Rossi's journey began with his graduation from Elmhurst College in 2006, followed by the attainment of his medical degree from the University of Sint Eustatius School of Medicine in 2012. Throughout his career, he has demonstrated an exceptional passion and talent for private medical practice management. Driven by the success of his proven model for private practice management, Dr. Rossi embarked on entrepreneurial ventures that laid the foundation for the achievements of Reditus.
In addition to serving referred and walk-in patients, Reditus Labs has emerged as a prominent leader in COVID laboratory testing for universities and local school districts. Their comprehensive approach includes providing personal protective equipment, on-site testing staff, and a user-friendly web-based portal that offers private access to test results.
Recognizing the critical role of Covid booster shots in the nation's economic recovery, Reditus has forged partnerships with corporate and government entities to facilitate on-site employee testing. Acknowledging that each site and population may present unique challenges and requirements, Reditus Labs tailors its services to meet specific needs. The company works closely with HR departments to implement effective communicable disease testing and surveillance programs. Their extensive program, known as "Reditus FluV19," enables the detection of COVID, Influenza A, and Influenza B.
When widespread testing of the general public becomes necessary, Reditus promptly organizes and conducts concierge events at public locations. These events offer convenient testing options, including drive-ups, walk-ins, and appointment-based services, ensuring accessibility for all. With a remarkable capacity to conduct over 40,000 Covid-19 tests per day and boasting a specificity and sensitivity rate surpassing 98.9%, Reditus has played a pivotal role in ensuring community safety and facilitating a return to normalcy.
At the helm of Reditus Laboratories is Dr. Aaron Rossi, MD, the esteemed founder and CEO. Dr. Rossi's journey began with his graduation from Elmhurst College in 2006, followed by the attainment of his medical degree from the University of Sint Eustatius School of Medicine in 2012. Throughout his career, he has demonstrated an exceptional passion and talent for private medical practice management. Driven by the success of his proven model for private practice management, Dr. Rossi embarked on entrepreneurial ventures that laid the foundation for the achievements of Reditus.